Developer of behavioral health integration technology designed to support coordinated care and informed decision-making in healthcare organizations. NeuroFlow is based in Philadelphia, PA. Its last known valuation is $307 million. It has raised $122 million across 5 recorded rounds; the latest was a $25.5 million early-stage round in Jul 2022.
Last price · $/share
—
Implied valuation
$307.0M
Total raised
$122.3M
Last round
Early Stage VC
Jul 2022
No prints on record
No secondary trades in NeuroFlow shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NeuroFlow with a free account
·The complete investor list: 45 names
·Watch NeuroFlow: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of NeuroFlow stock.
